SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ·Healthcare·Biotechnology
$10.21
-15.90%
Mkt Cap $2.29B
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$35.00
Range $35.00 – $35.00
Implied Upside
+243.0%
Consensus $35.00 vs current $10.21